Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Between the very common and the very rare – An opinionated take on NEJM highlights for October 2017

  • NEJM
Between the very common and the very rare – An opinionated take on NEJ…

Read more